Low-dose trimethoprim-sulfamethoxazole for Pneumocystis jiroveci pneumonia prophylaxis after allogeneic hematopoietic SCT.
T
T
Muto
M
M
Takeuchi
T
T
Kawaguchi
S
S
Tanaka
S
S
Tsukamoto
S
S
Sakai
Y
Y
Takeda
D
D
Abe
C
C
Ohwada
E
E
Sakaida
N
N
Shimizu
K
K
Yokote
T
T
Iseki
C
C
Nakaseko
D000293:Adolescent; D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D004338:Drug Combinations; D005260:Female; D019337:Hematologic Neoplasms / Q000401:mortality / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D045363:Pneumocystis carinii; D011020:Pneumonia, Pneumocystis / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D013413:Sulfadoxine / Q000008:administration & dosage*; D014184:Transplantation, Homologous; D014295:Trimethoprim / Q000008:administration & dosage*
D000890:Anti-Infective Agents; D004338:Drug Combinations; C000301:trimethoprim, sulfadoxine drug combination; D013413:Sulfadoxine; D014295:Trimethoprim